Without A Prescription

ARRENO Aggrenox

Home » Prescription Drugs 2 » ARRENO Aggrenox

The combination of aspirin and extended-release dipyridamole is in a class of drugs called antiplatelet agents. It works by preventing excessive blood clotting. It is used to reduce the risk of stroke in patients who have had or are at risk of stroke.The combination of aspirin and extended-release dipyridamole comes as a capsule to take by mouth. It is usually taken twice a day one capsule in the morning and one in the evening. Aspirin and extended-release dipyridamole should be swallowed whole. Do not open crush break or chew the capsules.The combination of aspirin and extended-release dipyridamole decreases the risk of having a stroke but does not eliminate that risk. Continue to take aspirin and extended-release dipyridamole even if you feel well. Do not stop taking aspirin and extended-release dipyridamole without talking to your doctor.

Buy ARRENO Aggrenox and other Prescription Drugs 2 products online at Medstore.

Buy Online at Medstore - Click Here!

About ARRENO Aggrenox:

Product Type: Prescription Drugs 2

ARRENO ( Aggrenox Generic Aspirin/Dipyridamole )

ARRENO (Aggrenox Generic Aspirin/Dipyridamole)

Aggrenox Generic Aspirin/Dipyridamole

25/200mg 3 x 60 Capsules-ER 60 Capsule-ER 2 x 60 Capsules-ER Aggrenox Generic Aspirin/Dipyridamole ARRENO

View more Prescription Drugs 2

Previous Product  Next Product

Without A Prescription: Education on antibiotic prescribing in Quebec worked. Guidelines for Quebec doctors on proper antibiotic use led to a decline in these prescriptions in the province, while prescribing rose in other provinces, a new study suggests. The guidelines were published and disseminated to Quebec doctors and pharmacists in January 2005 due to worries about the overuse of antibiotics and partly as a response to an outbreak of Clostridium difficile infections. Antibiotic consumption per capita was already 23.3 per cent higher in Canada generally than in Quebec in 2004, the study showed. But in the year that followed publication of the guidelines, the number of outpatient antibiotic prescriptions in Quebec decreased 4.2 per cent, the study said, while increasing 6.5 per cent in other Canadian provinces. The trend persisted three years later.